"Suction Tube Uterine Tamponade" for treatment of refractory postpartum hemorrhage: Internal feasibility and acceptability pilot of a randomized clinical trial

Int J Gynaecol Obstet. 2022 Jul;158(1):79-85. doi: 10.1002/ijgo.13963. Epub 2021 Oct 26.

Abstract

Objective: To assess feasibility and acceptability of a novel, low-cost "Suction Tube Uterine Tamponade" (STUT) treatment for refractory postpartum hemorrhage (PPH).

Methods: We allocated patients with refractory PPH by randomly ordered envelopes to STUT or routine uterine balloon tamponade (UBT, Ellavi free-flow system) in 10 hospitals in South Africa. In the STUT group, a 24FG Levin stomach tube was inserted into the uterine cavity and vacuum created with a vacuum pump or manual vacuum aspiration syringe.

Results: For this internal pilot study, 12 participants were allocated to STUT and 12 to UBT. Insertion failed in one of each group and was recorded as difficult in 3/10 STUT and 4/9 UBT insertions respectively (five missing data). There were two laparotomies and one intensive care unit admission in the UBT group. Pain during STUT insertion was graded as none/mild in 9/10 and severe in 1/10. The experience of the STUT procedure was graded as fine in 4/11 and "uncomfortable but acceptable" in 7/11.

Conclusion: STUT is feasible and acceptable, justifying continuation of our trial. These data will also inform a large World Health Organization trial to test effectiveness of uterine tamponade methods. The numbers are too small to support any clinical recommendation.

Keywords: acceptability; feasibility; internal pilot; postpartum hemorrhage; randomized clinical trial; suction tube uterine tamponade; uterine balloon tamponade.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Feasibility Studies
  • Female
  • Humans
  • Pilot Projects
  • Postpartum Hemorrhage* / therapy
  • Pregnancy
  • Suction
  • Treatment Outcome
  • Uterine Balloon Tamponade* / methods